About CME Group (NASDAQ:CME)

CME Group Inc., through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural products, and metals. The company executes trade through its electronic trading platforms, open outcry, and privately negotiated transactions, as well as provides hosting, connectivity, and customer support for electronic trading through its co-location services. It also provides clearing and settlement services for exchange-traded contracts, as well as for cleared swaps; and regulatory reporting solutions for market participants through its repository services in the United States, the United Kingdom, Canada, and Australia. In addition, the company offers a range of market data services, including live quotes, delayed quotes, market reports, and historical data services, as well as index services. It serves professional traders, financial institutions, institutional and individual investors, corporations, manufacturers, producers, governments, and central banks. The company was formerly known as Chicago Mercantile Exchange Holdings Inc. and changed its name to CME Group Inc. in July 2007. CME Group Inc. was founded in 1898 and is headquartered in Chicago, Illinois.
Industry, Sector and Symbol
Industry Security & commodity brokers, dealers, exchanges & services
Sub-IndustrySpecialized Finance
SectorFinance
SymbolNASDAQ:CME
CUSIP12572Q10
Phone312-930-1000
Debt
Debt-to-Equity Ratio0.10%
Current Ratio1.03%
Quick Ratio1.03%
Price-To-Earnings
Trailing P/E Ratio33.77
Forward P/E Ratio23.48
P/E Growth2.28
Sales & Book Value
Annual Sales$3.64 billion
Price / Sales15.04
Cash Flow$5.2987 per share
Price / Cash30.40
Book Value$66.07 per share
Price / Book2.44
Profitability
EPS (Most Recent Fiscal Year)$4.77
Net Income$4.06 billion
Net Margins111.49%
Return on Equity7.68%
Return on Assets2.11%
Miscellaneous
Employees2,830
Outstanding Shares340,390,000
CME Group (NASDAQ:CME) Frequently Asked Questions
What is CME Group's stock symbol?
CME Group trades on the NASDAQ under the ticker symbol "CME."
How often does CME Group pay dividends? What is the dividend yield for CME Group?
CME Group announced a quarterly dividend on Wednesday, February 7th. Investors of record on Friday, March 9th will be paid a dividend of $0.70 per share on Monday, March 26th. This represents a $2.80 annualized dividend and a dividend yield of 1.74%. The ex-dividend date of this dividend is Thursday, March 8th. This is a boost from CME Group's previous quarterly dividend of $0.66. View CME Group's Dividend History.
How were CME Group's earnings last quarter?
CME Group (NASDAQ:CME) announced its quarterly earnings results on Thursday, February, 1st. The financial services provider reported $1.12 earnings per share for the quarter, topping the Zacks' consensus estimate of $1.10 by $0.02. The financial services provider earned $900 million during the quarter, compared to analyst estimates of $886.85 million. CME Group had a net margin of 111.49% and a return on equity of 7.68%. The company's revenue for the quarter was down 1.4% on a year-over-year basis. During the same quarter in the prior year, the business posted $1.14 EPS. View CME Group's Earnings History.
When is CME Group's next earnings date?
What price target have analysts set for CME?
13 Wall Street analysts have issued 1-year price objectives for CME Group's stock. Their forecasts range from $133.00 to $197.00. On average, they anticipate CME Group's share price to reach $164.4615 in the next twelve months. View Analyst Ratings for CME Group.
Who are some of CME Group's key competitors?
Some companies that are related to CME Group include Intercontinental Exchange (ICE), T. Rowe Price (TROW), Deutsche Börse (DBOEY), Nasdaq (NDAQ), Cboe Global Markets (CBOE), LPL Financial (LPLA), BGC Partners (BGCP), INTL FCStone (INTL), Yintech Investment (YIN), OTC Markets Group (OTCM), National (NHLD) and Primus Guaranty (PRSG).
Who are CME Group's key executives?
CME Group's management team includes the folowing people:
- Mr. Terrence A. Duffy, Chairman & CEO (Age 60)
- Mr. Bryan Thomas Durkin, Pres (Age 57)
- Mr. John W. Pietrowicz, Sr. MD & CFO (Age 53)
- Mr. Sean P. Tully, Sr. MD and Global Head of Financial & OTC Products (Age 54)
- Ms. Julie Holzrichter, Sr. MD & COO (Age 49)
Has CME Group been receiving favorable news coverage?
Media stories about CME stock have trended positive on Wednesday, Accern reports. The research group identifies negative and positive news coverage by monitoring more than twenty million blog and news sources. Accern ranks coverage of companies on a scale of -1 to 1, with scores closest to one being the most favorable. CME Group earned a news impact score of 0.29 on Accern's scale. They also assigned news headlines about the financial services provider an impact score of 45.18 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the company's share price in the next several days.
How do I buy shares of CME Group?
Shares of CME can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
What is CME Group's stock price today?
One share of CME stock can currently be purchased for approximately $161.08.
How big of a company is CME Group?
CME Group has a market capitalization of $55.89 billion and generates $3.64 billion in revenue each year. The financial services provider earns $4.06 billion in net income (profit) each year or $4.77 on an earnings per share basis. CME Group employs 2,830 workers across the globe.
How can I contact CME Group?
CME Group's mailing address is 20 SOUTH WACKER DRIVE, CHICAGO IL, 60606. The financial services provider can be reached via phone at 312-930-1000 or via email at [email protected]
MarketBeat Community Rating for CME Group (CME)
MarketBeat's community ratings are surveys of what our community members think about CME Group and other stocks. Vote "Outperform" if you believe CME will outperform the S&P 500 over the long term. Vote "Underperform" if you believe CME will underperform the S&P 500 over the long term. You may vote once every thirty days.
CME Group (NASDAQ:CME) Price Target and Consensus Rating
(How are Consensus Ratings Calculated?) MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0-1.5 = Sell, 1.5-2.5 = Hold, 2.5-3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.
13 Wall Street analysts have issued ratings and price targets for CME Group in the last 12 months. Their average twelve-month price target is $164.4615, suggesting that the stock has a possible upside of 2.10%. The high price target for CME is $197.00 and the low price target for CME is $133.00. There are currently 3 hold ratings and 10 buy ratings for the stock, resulting in a consensus rating of "Buy."
| Today | 30 Days Ago | 90 Days Ago | 180 Days Ago |
Consensus Rating: | Buy | Buy | Buy | Buy |
Consensus Rating Score: | 2.77 | 2.75 | 2.67 | 2.73 |
Ratings Breakdown: | 0 Sell Rating(s) 3 Hold Rating(s) 10 Buy Rating(s) 0 Strong Buy Rating(s) | 0 Sell Rating(s) 3 Hold Rating(s) 9 Buy Rating(s) 0 Strong Buy Rating(s) | 0 Sell Rating(s) 4 Hold Rating(s) 8 Buy Rating(s) 0 Strong Buy Rating(s) | 0 Sell Rating(s) 3 Hold Rating(s) 8 Buy Rating(s) 0 Strong Buy Rating(s) |
Consensus Price Target: | $164.4615 | $157.25 | $144.8889 | $138.8889 |
Price Target Upside: | 2.10% upside | 6.35% downside | 6.52% downside | 1.85% upside |
CME Group (NASDAQ:CME) Consensus Price Target History

CME Group (NASDAQ:CME) Analyst Ratings History
Show:
(Data available from 4/25/2016 forward)
CME Group (NASDAQ:CME) Dividend Information
CME Group pays an annual dividend of $2.80 per share, with a dividend yield of 1.74%. CME's most recent quarterly dividend payment was Monday, March 26. CME Group pays out 58.70% of its earnings out as a dividend.
Most Recent Dividend: | 3/26/2018 |
Annual Dividend: | $2.80 |
Dividend Yield: | 1.74% |
Payout Ratio: | 58.70% (Trailing 12 Months of Earnings) 40.82% (Based on This Year's Estimates) 39.94% (Based on Next Year's Estimates)
|
CME Group (NASDAQ:CME) Dividend History by Quarter
Announced | Period | Amount | Yield | Ex-Dividend Date | Record Date | Payable Date |
---|
2/7/2018 | quarterly | $0.70 | 1.73% | 3/8/2018 | 3/9/2018 | 3/26/2018 |
12/6/2017 | | $3.50 | | 12/27/2017 | 12/28/2017 | 1/16/2018 |
12/6/2017 | None | $3.50 | | 12/27/2017 | 12/28/2017 | 1/15/2018 |
11/8/2017 | quarterly | $0.66 | 1.91% | 12/7/2017 | 12/8/2017 | 12/27/2017 |
8/2/2017 | quarterly | $0.66 | 2.11% | 9/7/2017 | 9/8/2017 | 9/25/2017 |
5/23/2017 | quarterly | $0.66 | 2.24% | 6/7/2017 | 6/9/2017 | 6/26/2017 |
2/8/2017 | quarterly | $0.66 | 2.23% | 3/8/2017 | 3/10/2017 | 3/27/2017 |
12/7/2016 | | $3.25 | | 12/23/2016 | 12/28/2016 | 1/13/2017 |
11/9/2016 | quarterly | $0.60 | 2.05% | 12/7/2016 | 12/9/2016 | 12/28/2016 |
8/3/2016 | quarterly | $0.60 | 2.3% | 9/7/2016 | 9/9/2016 | 9/26/2016 |
5/17/2016 | quarterly | $0.60 | 2.51% | 6/8/2016 | 6/10/2016 | 6/27/2016 |
2/3/2016 | quarterly | $0.60 | 2.71% | 3/8/2016 | 3/10/2016 | 3/28/2016 |
12/9/2015 | | $2.90 | | 12/23/2015 | 12/28/2015 | 1/12/2016 |
11/11/2015 | quarterly | $0.50 | 2.1% | 12/8/2015 | 12/10/2015 | 12/28/2015 |
8/5/2015 | quarterly | $0.50 | 2.06% | 9/8/2015 | 9/10/2015 | 9/25/2015 |
5/19/2015 | quarterly | $0.50 | 2.13% | 6/8/2015 | 6/10/2015 | 6/25/2015 |
2/4/2015 | quarterly | $0.50 | 2.2% | 3/6/2015 | 3/10/2015 | 3/25/2015 |
12/11/2014 | special | $2.00 | 2.12% | 12/24/2014 | 12/29/2014 | 1/13/2015 |
11/5/2014 | quarterly | $0.47 | 2.18% | 12/8/2014 | 12/10/2014 | 12/26/2014 |
8/6/2014 | quarterly | $0.47 | 2.57% | 9/8/2014 | 9/10/2014 | 9/25/2014 |
5/20/2014 | quarterly | $0.47 | 2.68% | 6/6/2014 | 6/10/2014 | 6/25/2014 |
2/5/2014 | quarterly | $0.47 | 2.48% | 3/6/2014 | 3/10/2014 | 3/25/2014 |
12/13/2013 | special | $2.60 | 2.21% | 12/24/2013 | 12/27/2013 | 1/14/2014 |
11/5/2013 | quarterly | $0.45 | 2.41% | 12/6/2013 | 12/10/2013 | 12/26/2013 |
8/7/2013 | quarterly | $0.45 | 2.49% | 9/6/2013 | 9/10/2013 | 9/25/2013 |
5/23/2013 | quarterly | $0.45 | 2.79% | 6/6/2013 | 6/10/2013 | 6/25/2013 |
1/30/2013 | quarterly | $0.45 | 3.11% | 3/6/2013 | 3/8/2013 | 3/25/2013 |
(Data available from 1/1/2013 forward)
CME Group (NASDAQ CME) Insider Trading and Institutional Ownership History
Insider Ownership Percentage: 0.45%
Institutional Ownership Percentage: 83.42%
CME Group (NASDAQ CME) Insider Trading History
Transaction Date | Insider Name | Title | Buy/Sell | Number of Shares | Average Share Price | Total Transaction | Shares Held After Transaction | Details |
---|
4/10/2018 | John W Pietrowicz | CFO | Sell | 2,500 | $161.02 | $402,550.00 | 34,957 | |
2/20/2018 | Hilda Harris Piell | Insider | Sell | 3,299 | $163.52 | $539,452.48 | | |
2/14/2018 | Ronald A Pankau | Director | Sell | 200 | $159.91 | $31,982.00 | 3,809 | |
2/6/2018 | Terrence A Duffy | Chairman | Sell | 20,000 | $151.66 | $3,033,200.00 | 99,239 | |
2/5/2018 | Leo Melamed | Director | Sell | 7,300 | $155.78 | $1,137,194.00 | 10,537 | |
2/2/2018 | Derek Sammann | Insider | Sell | 2,400 | $161.66 | $387,984.00 | 40,153 | |
1/9/2018 | John W Pietrowicz | CFO | Sell | 7,500 | $151.50 | $1,136,250.00 | 32,376 | |
12/18/2017 | Jack J Tobin | Insider | Sell | 2,325 | $152.28 | $354,051.00 | 17,574 | |
12/7/2017 | Julie Winkler | Insider | Sell | 2,457 | $150.41 | $369,557.37 | 16,318 | |
11/30/2017 | Jeffrey M Bernacchi | Director | Sell | 1,501 | $149.75 | $224,774.75 | 60,194 | |
11/30/2017 | Kimberly S Taylor | Insider | Sell | 8,125 | $150.00 | $1,218,750.00 | 120,590 | |
11/28/2017 | Julie Holzrichter | COO | Sell | 12,920 | $144.08 | $1,861,513.60 | | |
11/17/2017 | Sunil Cutinho | Insider | Sell | 2,600 | $139.57 | $362,882.00 | 22,301 | |
11/2/2017 | John W Pietrowicz | CFO | Sell | 5,175 | $139.70 | $722,947.50 | | |
10/11/2017 | John W Pietrowicz | CFO | Sell | 2,500 | $136.83 | $342,075.00 | | |
10/5/2017 | Hilda Harris Piell | Insider | Sell | 1,350 | $138.00 | $186,300.00 | | |
9/11/2017 | Dennis Suskind | Director | Sell | 750 | $129.34 | $97,005.00 | 5,059 | |
9/6/2017 | Hilda Harris Piell | Insider | Sell | 714 | $129.00 | $92,106.00 | 28,844 | |
8/28/2017 | Daniel R Glickman | Director | Sell | 850 | $126.65 | $107,652.50 | 13,799 | |
8/9/2017 | Martin J Gepsman | Director | Sell | 200 | $126.14 | $25,228.00 | 43,311 | |
8/8/2017 | Bryan T Durkin | President | Sell | 9,200 | $125.13 | $1,151,196.00 | 70,938 | |
8/7/2017 | Julie Holzrichter | COO | Sell | 11,915 | $125.67 | $1,497,358.05 | 43,657 | |
8/3/2017 | Ronald A Pankau | Director | Sell | 300 | $124.78 | $37,434.00 | 4,009 | |
8/2/2017 | Terrence A Duffy | Chairman | Sell | 21,815 | $123.89 | $2,702,660.35 | 110,711 | |
7/10/2017 | John W Pietrowicz | CFO | Sell | 2,500 | $124.50 | $311,250.00 | 38,495 | |
6/14/2017 | Kathleen M Cronin | Insider | Sell | 8,125 | $127.35 | $1,034,718.75 | 38,174 | |
6/13/2017 | Kimberly S Taylor | Insider | Sell | 7,400 | $125.95 | $932,030.00 | 115,330 | |
6/13/2017 | Timothy S Bitsberger | Director | Sell | 800 | $125.93 | $100,744.00 | 9,024 | |
6/12/2017 | Julie Winkler | Insider | Sell | 4,315 | $124.95 | $539,159.25 | 19,670 | |
6/9/2017 | Kevin Kometer | Insider | Sell | 4,125 | $122.44 | $505,065.00 | 54,820 | |
6/7/2017 | Derek Sammann | Insider | Sell | 2,100 | $118.24 | $248,304.00 | 36,595 | |
6/7/2017 | Julie Holzrichter | COO | Sell | 5,925 | $118.23 | $700,512.75 | 42,082 | |
6/5/2017 | Derek Sammann | Insider | Sell | 2,100 | $117.86 | $247,506.00 | 31,026 | |
5/24/2017 | Sunil Cutinho | Insider | Sell | 10,265 | $117.85 | $1,209,730.25 | 21,690 | |
4/28/2017 | Dennis Suskind | Director | Sell | 1,099 | $115.29 | $126,703.71 | 5,000 | |
4/10/2017 | John W Pietrowicz | CFO | Sell | 2,500 | $117.85 | $294,625.00 | 40,995 | |
3/14/2017 | Hilda Harris Piell | Insider | Sell | 3,043 | $124.26 | $378,123.18 | 26,082 | |
2/24/2017 | Julie Winkler | Insider | Sell | 5,888 | $122.53 | $721,456.64 | 14,095 | |
2/24/2017 | Ronald A Pankau | Director | Sell | 500 | $122.11 | $61,055.00 | 3,500 | |
2/3/2017 | Dennis Suskind | Director | Sell | 1,000 | $121.00 | $121,000.00 | 6,099 | |
1/9/2017 | John W Pietrowicz | CFO | Sell | 7,500 | $116.77 | $875,775.00 | 39,669 | |
12/29/2016 | Kimberly S Taylor | Insider | Sell | 1,351 | $115.88 | $156,553.88 | 99,607 | |
12/28/2016 | Bryan T Durkin | President | Sell | 14,886 | $116.39 | $1,732,581.54 | 65,960 | |
12/12/2016 | John W Pietrowicz | CFO | Sell | 4,625 | $123.30 | $570,262.50 | 51,794 | |
12/12/2016 | Ronald A Pankau | Director | Sell | 382 | $123.53 | $47,188.46 | 4,000 | |
12/9/2016 | Dennis Suskind | Director | Sell | 1,000 | $122.45 | $122,450.00 | 7,099 | |
12/8/2016 | Terrence A Duffy | CEO | Sell | 27,550 | $120.44 | $3,318,122.00 | 137,914 | |
12/7/2016 | Hilda Harris Piell | Insider | Sell | 5,850 | $120.00 | $702,000.00 | 29,500 | |
11/30/2016 | Bryan T Durkin | President | Sell | 15,000 | $112.85 | $1,692,750.00 | 68,680 | |
11/30/2016 | Kimberly S Taylor | Insider | Sell | 2,300 | $113.00 | $259,900.00 | 100,958 | |
11/25/2016 | Terrence A Duffy | CEO | Sell | 17,375 | $112.58 | $1,956,077.50 | 127,739 | |
11/2/2016 | Dennis Suskind | Director | Sell | 2,000 | $100.52 | $201,040.00 | 8,499 | |
10/31/2016 | Bryan T Durkin | Insider | Sell | 15,000 | $100.00 | $1,500,000.00 | 58,454 | |
9/29/2016 | Kimberly S Taylor | Insider | Sell | 2,300 | $106.01 | $243,823.00 | 105,558 | |
9/28/2016 | Bryan T Durkin | Insider | Sell | 14,990 | $105.10 | $1,575,449.00 | 66,936 | |
9/19/2016 | Hilda Harris Piell | Insider | Sell | 893 | $110.00 | $98,230.00 | 29,125 | |
9/19/2016 | Phupinder Gill | CEO | Sell | 30,002 | $110.00 | $3,300,220.00 | 116,222 | |
9/13/2016 | Jeffrey M Bernacchi | Director | Sell | 5,187 | $107.70 | $558,639.90 | 60,886 | |
9/6/2016 | Bryan T Durkin | Insider | Sell | 15,000 | $107.75 | $1,616,250.00 | 63,967 | |
9/2/2016 | Martin J Gepsman | Director | Sell | 300 | $109.00 | $32,700.00 | 42,802 | |
9/1/2016 | Dennis Suskind | Director | Sell | 1,000 | $109.49 | $109,490.00 | 10,099 | |
8/30/2016 | Kimberly S Taylor | Insider | Sell | 2,300 | $107.16 | $246,468.00 | 101,489 | |
8/15/2016 | Phupinder Gill | CEO | Sell | 20,080 | $104.54 | $2,099,163.20 | 154,141 | |
8/11/2016 | Ronald A Pankau | Director | Sell | 400 | $103.32 | $41,328.00 | 4,382 | |
8/4/2016 | Julie Holzrichter | COO | Sell | 2,425 | $103.03 | $249,847.75 | 32,620 | |
8/2/2016 | Derek Sammann | Insider | Sell | 3,550 | $103.20 | $366,360.00 | 30,896 | |
8/1/2016 | Kimberly S Taylor | Insider | Sell | 2,300 | $102.58 | $235,934.00 | 103,789 | |
7/15/2016 | James E Oliff | Director | Sell | 1,000 | $102.30 | $102,300.00 | | |
6/30/2016 | Kimberly S Taylor | Insider | Sell | 2,300 | $96.55 | $222,065.00 | 106,089 | |
6/28/2016 | Phupinder Gill | CEO | Sell | 31,120 | $93.14 | $2,898,516.80 | 165,181 | |
6/13/2016 | Kevin Kometer | Insider | Sell | 3,825 | $95.50 | $365,287.50 | 46,351 | |
6/6/2016 | John W Pietrowicz | CFO | Sell | 3,900 | $96.72 | $377,208.00 | 46,393 | |
6/6/2016 | Kathleen M Cronin | Insider | Sell | 6,200 | $96.84 | $600,408.00 | 30,774 | |
6/3/2016 | Kimberly S Taylor | Insider | Sell | 7,400 | $96.38 | $713,212.00 | 115,789 | |
5/31/2016 | Kimberly S Taylor | Insider | Sell | 2,300 | $98.62 | $226,826.00 | 108,389 | |
4/28/2016 | Kimberly S Taylor | Insider | Sell | 2,300 | $92.68 | $213,164.00 | 110,689 | |
3/30/2016 | Kimberly S Taylor | Insider | Sell | 2,300 | $95.62 | $219,926.00 | 112,989 | |
3/11/2016 | Kevin Kometer | Insider | Sell | 500 | $93.93 | $46,965.00 | 38,305 | |
3/9/2016 | Terrence A Duffy | Chairman | Sell | 15,340 | $93.51 | $1,434,443.40 | 92,244 | |
3/4/2016 | Hilda Harris Piell | Insider | Sell | 252 | $95.00 | $23,940.00 | 22,618 | |
3/1/2016 | John W Pietrowicz | CFO | Sell | 500 | $91.68 | $45,840.00 | 39,979 | |
2/26/2016 | Ronald A Pankau | Director | Sell | 200 | $93.50 | $18,700.00 | 3,707 | |
2/22/2016 | Hilda Harris Piell | Insider | Sell | 1,145 | $94.00 | $107,630.00 | 24,015 | |
12/3/2015 | Robert Zagotta | Insider | Sell | 2,224 | $95.71 | $212,859.04 | 12,968 | |
10/30/2015 | James E Oliff | Director | Sell | 1,000 | $94.91 | $94,910.00 | | |
6/12/2015 | Kathleen M Cronin | Insider | Sell | 6,500 | $98.44 | $639,860.00 | | |
6/3/2015 | Kathleen M Cronin | Insider | Sell | 2,000 | $95.00 | $190,000.00 | | |
6/2/2015 | John W Pietrowicz | CFO | Sell | 1,010 | $93.59 | $94,525.90 | | |
6/1/2015 | Phupinder Gill | CEO | Sell | 5,000 | $94.02 | $470,100.00 | | |
5/29/2015 | Terrence A Duffy | Chairman | Sell | 29,496 | $93.87 | $2,768,789.52 | | |
5/27/2015 | Kevin Kometer | Insider | Sell | 4,500 | $94.02 | $423,090.00 | | |
4/2/2015 | John W Pietrowicz | CFO | Sell | 1,000 | $94.68 | $94,680.00 | | |
3/20/2015 | Phupinder Gill | CEO | Sell | 30,000 | $99.76 | $2,992,800.00 | | |
3/16/2015 | Jill A Harley | CAO | Sell | 1,950 | $100.00 | $195,000.00 | | |
3/16/2015 | Kimberly S Taylor | Insider | Sell | 13,000 | $100.00 | $1,300,000.00 | | |
2/25/2015 | Derek Sammann | Insider | Sell | 4,770 | $96.54 | $460,495.80 | | |
2/11/2015 | Terrence A Duffy | Chairman | Sell | 30,875 | $94.55 | $2,919,231.25 | | |
2/6/2015 | Hilda Harris Piell | Insider | Sell | 1,600 | $94.00 | $150,400.00 | | |
12/8/2014 | Hilda Harris Piell | Insider | Sell | 5,825 | $89.00 | $518,425.00 | | |
11/3/2014 | Kathleen M Cronin | Insider | Sell | 1,920 | $84.52 | $162,278.40 | | |
11/3/2014 | Terrence A Duffy | Chairman | Sell | 14,580 | $84.55 | $1,232,739.00 | | |
10/1/2014 | Jill A Harley | CAO | Sell | 1,200 | $79.99 | $95,988.00 | | |
9/15/2014 | Hilda Harris Piell | Insider | Sell | 5,497 | $79.41 | $436,516.77 | | |
9/15/2014 | Jill A Harley | CAO | Sell | 2,820 | $80.00 | $225,600.00 | | |
9/2/2014 | Bryan T Durkin | COO | Sell | 25,625 | $76.75 | $1,966,718.75 | | |
7/23/2014 | Hilda Harris Piell | Insider | Sell | 2,282 | $75.00 | $171,150.00 | | |
7/23/2014 | Jill A Harley | CAO | Sell | 2,710 | $75.00 | $203,250.00 | | |
6/2/2014 | Phupinder Gill | CEO | Sell | 49,000 | $71.66 | $3,511,340.00 | | |
5/22/2014 | Hilda Harris Piell | Insider | Sell | 4,730 | $70.00 | $331,100.00 | 21,135 | |
5/21/2014 | C Odom II | Director | Sell | 2,000 | $69.62 | $139,240.00 | 3 | |
3/6/2014 | Phupinder Gill | CEO | Sell | 25,000 | $77.00 | $1,925,000.00 | 114,365 | |
2/19/2014 | C Odom II | Director | Sell | 2,000 | $75.91 | $151,820.00 | 2,003 | |
2/12/2014 | C Odom II | Director | Sell | 2,000 | $76.04 | $152,080.00 | 4,003 | |
2/6/2014 | C Odom II | Director | Sell | 2,000 | $73.59 | $147,180.00 | 6,003 | |
11/19/2013 | C Odom II | Director | Sell | 1,532 | $80.03 | $122,605.96 | 8,503 | |
9/16/2013 | James Pieper | CAO | Sell | 3,785 | $72.47 | $274,298.95 | 4,793 | |
9/4/2013 | Linda Dallas Rich | Insider | Sell | 1,737 | $72.50 | $125,932.50 | | |
8/29/2013 | James Pieper | CAO | Sell | 8,584 | $70.33 | $603,712.72 | 4,762 | |
8/15/2013 | Derek Sammann | Insider | Sell | 10,530 | $74.78 | $787,433.40 | 18,100 | |
8/14/2013 | Derek Sammann | Insider | Sell | 2,500 | $74.11 | $185,275.00 | 18,100 | |
6/17/2013 | Hilda Harris Piell | Insider | Sell | 5,315 | $75.00 | $398,625.00 | | |
6/12/2013 | Kathleen M Cronin | Insider | Sell | 3,135 | $72.66 | $227,789.10 | | |
5/30/2013 | Hilda Harris Piell | Insider | Sell | 2,100 | $70.00 | $147,000.00 | | |
5/28/2013 | James E Parisi | CFO | Sell | 37,000 | $65.72 | $2,431,640.00 | | |
5/20/2013 | Hilda Harris Piell | Insider | Sell | 2,600 | $64.78 | $168,428.00 | | |
3/12/2013 | C C Odom II | Director | Sell | 2,243 | $62.54 | $140,277.22 | | |
3/12/2013 | Ken Vroman | Insider | Sell | 1,492 | $62.69 | $93,533.48 | | |
3/11/2013 | Kevin Kometer | Insider | Sell | 10,443 | $62.42 | $651,852.06 | | |
1/17/2013 | Linda Dallas Rich | Insider | Sell | 4,350 | $55.00 | $239,250.00 | | |
(Data available from 1/1/2013 forward)
CME Group (NASDAQ CME) News Headlines
Source: |
|
CME Group (NASDAQ:CME) SEC Filings
This page is loading this company's SEC Filings. Please wait...
CME Group (NASDAQ:CME) Income Statement, Balance Sheet and Cash Flow Statement
CME Group (NASDAQ CME) Stock Chart for Wednesday, April, 25, 2018
Loading chart…